As of 2026-06-07, the Relative Valuation of CHC Healthcare Group (4164.TW) is 17.67 TWD. This relative valuation is based on P/E multiples. With the latest stock price at 30.05 TWD, the upside of CHC Healthcare Group based on Relative Valuation is -41.2%.
The range of the Relative Valuation is 12.95 - 23.14 TWD.
| Range | Selected | |
| Trailing P/E multiples | 12.4x - 15.1x | 13.7x |
| Forward P/E multiples | 11.9x - 13.8x | 12.5x |
| Fair Price | 12.95 - 23.14 | 17.67 |
| Upside | -56.9% - -23.0% | -41.2% |
| Date | P/E |
| 2026-05-22 | 27.62 |
| 2026-05-21 | 27.38 |
| 2026-05-20 | 27.09 |
| 2026-05-19 | 27.19 |
| 2026-05-18 | 27.33 |
| 2026-05-15 | 26.86 |
| 2026-05-14 | 26.71 |
| 2026-05-13 | 26.95 |
| 2026-05-12 | 27.29 |
| 2026-05-11 | 27.76 |
| 2026-05-08 | 27.29 |
| 2026-05-07 | 28.15 |
| 2026-05-06 | 27.96 |
| 2026-05-05 | 28.29 |
| 2026-05-04 | 27.72 |
| 2026-04-30 | 27.81 |
| 2026-04-29 | 28.20 |
| 2026-04-28 | 27.96 |
| 2026-04-27 | 28.63 |
| 2026-04-24 | 29.20 |
| 2026-04-23 | 29.39 |
| 2026-04-22 | 30.83 |
| 2026-04-21 | 31.35 |
| 2026-04-20 | 31.07 |
| 2026-04-17 | 29.82 |
| 2026-04-16 | 30.11 |
| 2026-04-15 | 29.58 |
| 2026-04-14 | 29.54 |
| 2026-04-13 | 29.44 |
| 2026-04-10 | 30.16 |
| 2026-04-09 | 29.82 |
| 2026-04-08 | 30.11 |
| 2026-04-07 | 29.63 |
| 2026-04-02 | 29.63 |
| 2026-04-01 | 29.68 |
| 2026-03-31 | 28.87 |
| 2026-03-30 | 28.82 |
| 2026-03-27 | 29.01 |
| 2026-03-26 | 29.39 |
| 2026-03-25 | 30.16 |
| 2026-03-24 | 29.25 |
| 2026-03-23 | 29.49 |
| 2026-03-20 | 29.54 |
| 2026-03-19 | 29.54 |
| 2026-03-18 | 29.78 |
| 2026-03-17 | 31.74 |
| 2026-03-16 | 29.49 |
| 2026-03-13 | 29.58 |
| 2026-03-12 | 29.39 |
| 2026-03-11 | 29.63 |